Pharmacokinetics/Pharmacodynamics Flashcards

1
Q

“the drug’s effect on the body”

therapeutic and/or toxic doses

Sensitivity and responsiveness of receptors

Variability from person to person

Mechanism of action

effective dose (ED)

A

Pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When is a drug considered eliminated?

A

when 95% has been eliminated – usually 4-5 elimination ½ lives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The time for the drug in the plasma to decrease by 50%; affected by volume of distribution and changes in clearance.

A

Elimination ½ life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The time for the plasma drug concentration to decrease by 50% after discontinuing a continuous infusion of a specific duration

A

Context-Sensitive Half-Time (infusion duration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which drug has a short context-sensitive half-time?

A

remifentanyl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The half-time of equilibration between drug concentration in the blood and the drug effect*

Accounts for the delay between IV injection into the plasma and the delivery of the drug to its site of action

Important for redosing intervals!

A

Effect-Site Equilibration Time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Number to describe the apparent volumes of compartments that constitute the compartmental model.

Describes the distribution characteristic of a drug in the body.

Calculated – dose of drug given divided by the resulting plasma concentration prior to elimination (at maximal concentration)

A

Volume of Distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Volume of Distribution effected by?

A

1) Lipid solubility
2) Binding to plasma proteins
3) Molecular size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Large Vd Drug

A

propofol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

small Vd drug (MOSTLY IN PLASMA)

A

NMB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which drug has more effect, bound or unbound?

A

unbound (in the plasma, can cross cell membrane, not bound to the protein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is an ionized drug?

A

WATER-soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a nonionized drug?

A

LIPID-soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What 4 areas are lipid soluble?

A

blood-brain barrier
renal tubules
GI endothelium
placental barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

high vD

A

low protein binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

low vD

A

high protein binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

One effective dose plus another effective dose

1 + 1 = 2

Sebo and nitrous

A

Additive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Given together to create a bigger effect

1 + 1 = 3

fentanyl and midazolam

A

Synergistic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Enhancement of one drug action by second drug with no action of its own

1 + 0 = 3

A

Potentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Working against each other

1 + 1 = 0

Fentanyl and nalaxone

A

Antagonistic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Having or showing abnormally high sensitivity to stimuli

such as bronchial response to an irritant

A

Hyperreactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Abnormally susceptible physiologically to a specific agent

can be an immune-mediated response

A

Hypersensitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Having or showing abnormally low sensitivity to stimuli

A

Hyporeactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What type of response can occur with a person on an antihypertensive drug given vasodilation?

A

Hypersensitive

hypersensitive to vasodilation, super responsive, extremes of BP lows and highs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What type of response can occur with a person who chronically uses oxy for back pain?
Hyporeactive developed a tolerance, may have low sensitivity to narcotics
26
The difference between the usual effective/therapeutic dose and the dose that causes severe or life-threatening side effects (toxic)
Safety margin
27
the capacity of the body to endure or become less responsive to a substance (as a drug) or a physiological insult especially with repeated use or exposure
tolerance
28
diminished response to later increments in a sequence of applications of a physiologically active substance less of a response the next times you give it (second dose often needs to be larger)
Tachyphylaxis
29
Example of tachyphylaxis?
ephidrine
30
what is ED50?
effective dose in 50% of patients
31
A substance that binds to a specific receptor and triggers a response in the cell. Mimics the action of an endogenous ligand that binds to the same receptor
Agonist
32
Can some drugs be partial agonists and antagonists?
Yes Activates a receptor, but cannot produce a maximum response May partially block effect of full agonists Lower efficacy than a full agonist
33
A drug that has affinity/potency for the receptor, but no efficacy does NOT activate the receptor to produce a physiologic action.
Antagonist
34
Does an antagonist produce a physiologic action?
no, it produces a CONSEQUENCE (block of the response)
35
What type of antagonist is reversible?
Competitive
36
What type of antagonist is irreversible?
non-competitive
37
Two agonist drugs that bind to different receptors – causing opposing responses
Physiologic antagonism
38
NO receptor activity is involved – one drug binds with the second drug to inactivate it
Chemical antagonism
39
example of chemical antagonism?
protamine and heparin
40
example of physiologic antagonism?
vasodilation v. vasoconstriction
41
the component of a cell that interacts with a drug and initiates the chain of events leading to the drug’s effect
Receptor
42
What is responsible for the selectivity of drug action?
receptor
43
the degree of drug receptor interaction for a given drug
affinity/potency
44
drug’s ability to produce desired response (maximum effect)
efficacy/intrinsic activity
45
Maximal or nearly maximal response can often be produced by activation of only a fraction of the receptors present
Spare receptor concept
46
Is the relationship between the number of receptors stimulated and the response usually: linear OR nonlinear?
NONlinear Example: muscle receptors and antagonists – takes 70% of receptors blocked before reduction in muscle response – only 30% of receptors activated by ACh produces maximal response
47
occurs with continued stimulation of cells with agonists – the effect is diminished
Down-regulation/Desensitization Example: beta agonist bronchodilators – tolerance develops from repeated use – increased dose required for same effect
48
chronic exposure to antagonists cause receptor number and sensitivity to increase
Up-regulation Example: Beta-blockers cause up regulation of receptors if taking beta blocker on regular basis, have them continue on morning of surgery if level is too low, there will be increase of beta 1 receptors, so there is going to be exaggerated response (greater tachycardia, etc.)
49
what type of drug binds to circulating protein receptors?
drugs affecting components of the coagulation cascade
50
AGE Variability of Pharmacologic Response
neonates (not ready yet, not good enzymes, large water content, there response to water soluble vs lipid soluble) 80s age (dehydrated, malnourished, things are starting to fail)
51
SEX Variability of Pharmacologic Response
NMBs (guys have a higher muscle content than men, could possibly impact duration)
52
Pathological State (PS) Variability of Pharmacologic Response
muscular dystrophy, myasthenia gravis
53
Variability of Pharmacologic Response
Age Sex Body weight Body surface area Basal metabolic rate Pathologic state Genetic profile
54
the actions of the body on the drug Absorption Distribution Metabolism Elimination of drugs and metabolites
Pharmacokinetics
55
What is another word for absorption?
bioavailability
56
What types of routes are effected by first-pass effect?
PO, rectal
57
circulation through the liver
first-pass effect
58
where does sublingual go?
superior vena cava
59
where does fentanyl and sufentanyl go first?
lungs
60
What are the components of the Two Compartment Model
distribution (alpha) elimination (beta)
61
what is elimination phase?
metabolism and excretion
62
what is distribution phase?
central (vessel rich group, then muscle, then fat, than redistributed) to peripheral
63
% for Fat Group
”im fat and 26" 6% CO and 20% body mass
64
% for Muscle Group
"People are more muscley at 19 than 50" 19% CO, 50% body mass
65
% for VRG
"wise with the brain at age 75" 75% CO, body mass 10%
66
what is the VRG (5 places)
brain heart liver kidney endocrine
67
does metabolism always create inactive metabolites?
no Morphine-6-glucuronide is more potent than morphine itself Prodrug – metabolized to an active drug – codeine to morphine
68
what are 5 sites for metabolism?
MOSTLY Hepatic microsomal enzymes Plasma – Hofmann elimination Lungs Kidneys Gastrointestinal tract
69
what effects Hoffman elimination?
temperature and pH
70
Does enzyme induction impact inner patient variability?
yes taking certain medications can increase metabolism of drugs
71
Hepatic microsomal enzymes mostly Oxidative metabolism of most drugs
Cytochrome P-450 Enzymes
72
The ability of drugs or chemicals to stimulate activity of the cytochrome P450 system.
Enzyme induction
73
Non-microsomal enzymes Metabolism by conjugation, hydrolysis, and some oxidation and reduction Present largely in the liver, but also found in the plasma and GI tract
NON-cytochrome P-450 Enzymes (Esters) plasma cholinESTERase, plasma ESTERases
74
Are NON-cytochrome P-450 Enzymes (Esters) inducible?
NO
75
Can NON-cytochrome P-450 Enzymes (Esters) be altered by genetics?
YES
76
what are phase I enzymes?
Cytochrome P-450 Enzymes NON-cytochrome P-450 Enzymes (Esters)
77
are FAST or SLOW acetylators are at greater risk for side-effects?
SLOW
78
What are the 2 major sites of elimination?
kidneys and the liver
79
ED50 is an example of what*
pharmacodynamics (drug effecting the body)
80
CSHT is effected by what 3 things*
distribution, metabolism, duration